# PALIPERIDONE
> **ANDA218755** · Abbreviated New Drug Application (Generic) · Sponsor: ESKAYEF · Approved 2025-09-04
## Drug
- **FDA Application Number:** ANDA218755
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PALIPERIDONE
- **Generic name:** PALIPERIDONE
- **Active ingredients:** PALIPERIDONE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ESKAYEF
- **Manufacturer:** Eskayef Pharmaceuticals Limited
- **First approval:** 2025-09-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218755)
---
*AI Analytics · CC0 1.0*